Operation Warp Speed is living up to its name, as the Trump administration continues to strike landmark vaccine deals at epic proportions. At this rate, America could have more than half a billion vaccine doses by the end of this year.
Johnson & Johnson announced on Wednesday they have agreed to a deal with the federal government that guarantees 100 million doses of a coronavirus vaccine by the end of 2020. The deal, which is valued at more than $1 billion, was secured through the US Department of Defense and BARDA (Biomedical Advanced Research and Development).
If the vaccine is developed and delivered on time, the US government will also be able to purchase an additional 200 million doses under the deal.
The pharmaceutical giant posted the news on Twitter, including a statement from the company’s Chief Scientific Officer and Vice Chair of the Executive Committee, Dr. Paul Stoffels who said, “We greatly appreciate the U.S. government’s confidence in, and support for, our R&D platform and efforts and the scalability of our vaccine technology. We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use.”
#JNJ announced @JanssenGlobal has entered into an agreement that will result in the production & delivery of 100 million doses of Janssen’s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the U.S. following FDA approval. https://t.co/IQK2BM3k3d pic.twitter.com/7PPUddcTh3
— Johnson & Johnson (@JNJNews) August 5, 2020
Throughout the White House coronavirus task force press briefings, Johnson and Johnson has been one of the top companies Trump has said is making great progress on the race for a vaccine. The government’s vaccine partnership with the pharmaceutical company comes just two weeks after the first DOD-Pharma vaccine deal with Pfizer.
The Pfizer deal, which has a higher valuation at nearly $2 billion, also guarantees 100 million vaccine doses by the end of December, plus 200 million doses by January 2021.
HHS Secretary Alex Azar confirmed that Pfizer and Johnson and Johnson are closest to a successful vaccine and revealed that at least four others are coming very close with reports of positive phase one clinical trial results.
During a Wednesday interview with Fox News, Azar even suggested a working and tested vaccine could come as soon as this fall. If not then, he said, “It is very credible that we will have the high tens of millions of doses of FDA gold-standard vaccine by the end of this year, and many hundreds of millions of doses of vaccine by the beginning of next year.”
In regards to the testing capacity on which the Left has hammered the Trump administration, the HHS Secretary confirmed, “Yes, we have got major advances coming with testing capacity, but we have also got to make sure the right people are getting tested,” he said.
If the government buys out all of Pfizer’s and Johnson and Johnson’s vaccines, we will be stocked with a staggering 600 million vaccine doses by January 2021. While there is still a huge divide on people who will voluntarily get one and who won’t, we can all agree that there will be absolutely no reason to keep our country shut down when we have every possible tool available to fight off a contagious virus. We don’t have to be vaccine proponents to be excited about the fact that this will at least mark the end of the pandemic.